Yahoo Finance • a day ago
Despite some turbulence, growth stocks have been on a bull run since the 2008 financial crisis. Groundbreaking innovations in technology and healthcare have been the primary drivers behind this trend. Which growth stocks stand out as top... Full story
Yahoo Finance • a day ago
After losing more than 90% of its value from a peak back in 2021, Novavax(NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing deal with French pharmac... Full story
Yahoo Finance • 6 days ago
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED) Editor’s note: This story has been updated to correct an error in the price a... Full story
Yahoo Finance • 7 days ago
Since the page turned to 2023 a little over 16 months ago, the bulls have been running wild on Wall Street. Professional and everyday investors have flocked to high-growth, innovation-driven businesses, and have been particularly enamored... Full story
Yahoo Finance • 2 months ago
Novavax, Inc. (NASDAQ:NVAX) missed earnings with its latest full-year results, disappointing overly-optimistic forecasters. Revenues missed expectations somewhat, coming in at US$984m, but statutory earnings fell catastrophically short, wi... Full story
Yahoo Finance • 3 months ago
We feel now is a pretty good time to analyse Novavax, Inc.'s (NASDAQ:NVAX) business as it appears the company may be on the cusp of a considerable accomplishment. Novavax, Inc., a biotechnology company, that promotes improved health by dis... Full story
Yahoo Finance • 3 months ago
The S&P 500 last month reached a new record high, officially confirming that we are in a bull market. This environment may feel new, but the index actually has been in bull territory ever since it started to rebound from bear market lows 1... Full story
Yahoo Finance • 4 months ago
Over the long run, Wall Street has proved to be a surefire wealth creator. But over shorter periods, the performance of the major stock indexes is unpredictable. Since this decade began, the Dow Jones Industrial Average, S&P 500, and Nasda... Full story
Yahoo Finance • 4 months ago
Novavax(NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as quickly as planned. Novavax's product launched... Full story
Yahoo Finance • 4 months ago
For optimists, 2023 was a stellar year. The ageless Dow Jones Industrial Average climbed to a fresh all-time high, while the S&P 500 and Nasdaq Composite logged respective gains of 24% and 43% by the time the curtain closed. But just beca... Full story
Yahoo Finance • 4 months ago
GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th Annual J.P. Morgan Healthcare... Full story
Yahoo Finance • 4 months ago
What a difference a year can make on Wall Street. After enduring two bear markets in less than three years, all three major indexes soared in 2023. The iconic Dow Jones Industrial Average climbed to a record high, while the broad-based S&P... Full story
Yahoo Finance • 5 months ago
Novavax launches Choose to Protect™ campaign to educate public about importance of updated COVID-19 vaccination Recent survey finds that 70% of Canadians believe in the value of COVID-19 vaccination; 74% want to select the COVID-19 vaccine... Full story
Yahoo Finance • 5 months ago
Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md., Dec. 5, 2023 /CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing p... Full story
Yahoo Finance • 5 months ago
Biotech company Novavax (NASDAQ: NVAX) went from being relatively unknown just four years ago to becoming one of the U.S. COVID-19 vaccine market leaders. The company has faced many trials and tribulations in this period, however. If Novav... Full story
Yahoo Finance • 6 months ago
A lot can happen in just a few years, and Novavax (NASDAQ: NVAX) is the proof of that. Three years ago, the company was rushing toward the coronavirus vaccine finish line -- and the shares were soaring. Novavax brought its vaccine to marke... Full story
Yahoo Finance • 6 months ago
Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only protein-based non-mRNA vaccine option Secured broad access to Novavax's COVID-19 vaccine i... Full story
Yahoo Finance • 6 months ago
Warner Bros. Discovery (NASDAQ:WBD) experienced a significant drop in its stock value, plunging 18% after releasing disappointing earnings results. Despite having the year's top-grossing movie, "Barbie," the company's shares suffered due t... Full story
Yahoo Finance • 6 months ago
Novavax stock is on the rise as it gains new approvals and authorizations for its Covid vaccine? Is NVAX stock a buy right now? Continue reading... Full story
Yahoo Finance • 6 months ago
GAITHERSBURG, Md., Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its third quarter 2023 financial results and operat... Full story